Elizabeth A. Browning
Plus aucun poste en cours
Profil
Elizabeth A.
Browning is the founder of LLuminari, Inc. She previously worked as a Director at First State Innovation, Inc. and as an Executive Vice President-Marketing & Sales at Fibrocell Science, Inc. from 2012 to 2013.
Anciens postes connus de Elizabeth A. Browning
| Sociétés | Poste | Fin |
|---|---|---|
| LLuminari, Inc. | Fondateur | 01/01/2011 |
| FIBROCELL SCIENCE, INC. | Sales & Marketing | - |
First State Innovation, Inc.
 First State Innovation, Inc. Financial ConglomeratesFinance First State Innovation, Inc. provides investment services to technology-based and early stage businesses. It services include seed capital, alternative funding, skilled human capital, commercialization assistance, intellectual capital and other entrepreneurial resource services. The firm also provides biotechnology and life sciences, advanced materials, information technology, nanotechnology, financial services and supporting infrastructure. The company was founded in 2006 and is headquartered in Wilmington, DE. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
First State Innovation, Inc.
First State Innovation, Inc. Financial ConglomeratesFinance First State Innovation, Inc. provides investment services to technology-based and early stage businesses. It services include seed capital, alternative funding, skilled human capital, commercialization assistance, intellectual capital and other entrepreneurial resource services. The firm also provides biotechnology and life sciences, advanced materials, information technology, nanotechnology, financial services and supporting infrastructure. The company was founded in 2006 and is headquartered in Wilmington, DE. | Finance |
| LLuminari, Inc. | |
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on September 28, 1992 and is headquartered in Exton, PA. | Health Technology |
